The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

被引:79
作者
Lundberg I.E. [1 ]
机构
[1] Department of Rheumatology, Karolinska Hospital, Stockholm
关键词
Muscle Tissue; Myositis; Dermatomyositis; Inclusion Body Myositis; Inflammatory Myopathy;
D O I
10.1007/s11926-000-0082-y
中图分类号
学科分类号
摘要
Cytokines, chemokines, and adhesion molecules are important mediators in chronic inflammation and in immune regulation. In idiopathic inflammatory myopathies (IIM), increased expression of proinflammatory cytokines particularly interleukin (IL)-1alpha and IL-1beta, tumor necrosis factor (TNF)-alpha and macrophage inflammatory proteins (MIP)-1alpha, as well as of the inhibitory cytokines transforming growth factor (TGF)-beta was observed in muscle. There was no difference in cytokine and chemokine pattern between polymyositis, dermatomyositis, and inclusion body myositis, which could indicate that similar pathogenetic mechanisms are involved in these subsets of myositis. A prominent finding of IL-1alpha expression in endothelial cells, both in patients with active inflammation and in patients with chronic persisting muscle weakness without inflammation, makes this an interesting molecule in understanding the mechanisms for the pathogenesis of muscle weakness. Involvement of the blood vessels in the pathogenesis of myositis was further supported by increased expression of adhesion molecules and by a phenotypical expression of endothelial cells, resembling high endothelium venules in all three subsets of IIM. The molecular studies to date indicate a role of the microvessels in the pathogenesis of IIM not only in DM, as was previously suggested, but also in PM and IBM. The studies also indicate that IL-1alpha could be a target molecule for new therapeutical interventions.
引用
收藏
页码:216 / 224
页数:8
相关论文
共 156 条
[1]  
Dalakas MC(1991)Polymyositis, dermatomyositis, and inclusionbody myositis N Engl J Med 325 1487-1498
[2]  
Arahata K(1984)Monoclonal antibody analysis of mononuclear cells in myopathies: I. quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells Ann Neurol 16 193-208
[3]  
Engel AG(1986), Hum Pathol 17 704-721
[4]  
Engel AG(1988)Expression of immunoreactive major histocompatibility complex products in human skeletal muscles Ann Neurol 23 64-72
[5]  
Arahata K(1989)Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies Hum Pathol 20 224-231
[6]  
Karpati G(1990)Microvascular changes in early and advanced dermatomyositis: a quantitative study Ann Neurol 27 343-356
[7]  
Poulior Y(1975)Polymyositis: its presentation, morbidity, and mortality Brain 98 637-666
[8]  
Carpenter S(1993)Autoimmune recognition of cartilage collagens Ann Med 25 251-264
[9]  
Emslie-Smith AM(1998)Pathogenesis of neuroimmunologic diseases: experimental models Immunol Res 17 217-227
[10]  
Arahata K(1989)Current concepts in the idiopathic inflammatory myopathies:polymyositis, dermatomyositis, and related disorders Am J Med 111 143-157